Doctoral and Postdoctoral Research Fellowships in Myotonic Dystrophy
Recognizing that the symptoms and the severity of the condition vary widely among affected people and often severely impact activities of daily living and functioning, the MDF is expanding the scientific research endeavors eligible for Doctoral and Postdoctoral Fellowship awards to include research focused on improving treatment, care, and support of the DM patient and his/her family, as well as molecular biology and basic science. In 2022 MDF will prioritize funding at least one project focused on DM2 and will accept and consider proposals for both DM1 and DM2. The MDF is actively soliciting Doctoral and Postdoctoral fellowship proposals for basic, clinical, or applied research directly related to myotonic dystrophy in:
Pathogenesis
Molecular basis underlying phenotype differences (Type 1, 2, congenital)
Development of diagnostics and biomarkers
Progression/natural history
Identification and validation of drug treatment endpoints
Standards of care and care integration, including nursing, social work, and psychology
Epidemiology, economics, and support services
Therapeutic development, particularly, but not limited to, early stage projects where success can leverage larger investments
2 years
Upper $105,000USD Lower $55,000USD
The fellowship is for a two-year period, with second year funding dependent on successful completion of the first year’s stated objectives. Doctoral and Postdoctoral Fellow awards are made to the applicant organization on behalf of the fellow.
Predoctoral Award: $55,000 for salary, benefits, travel, and research support, paid over two years:
$5,000 of the award is for required travel to the Myotonic Annual Conference, and to the biennial IDMC meetings.
Postdoctoral Award: $105,000 for salary, benefits, travel, and research support, paid over two years:
$5,000 of the award is for required travel to the Myotonic Annual Conference, and to the biennial IDMC meetings
Doctoral applicants must be enrolled and in good standing in a Ph.D. program at an accredited academic medical center or research institute. By the time of award, the applicant must have completed two years of a doctoral program, including formal coursework and any qualifying examination requirements, and have selected a sponsor who focuses a major portion of his or her lab’s activities on DM.
Postdoctoral applicants must have a Ph.D., M.D., D.O. or equivalent degree from an accredited institution. Degree must have been received within no more than three years of the time of the award. The sponsor of the applicant must focus a major portion of his or her lab’s activities on DM.
Co-sponsors are encouraged when projects utilize a multidisciplinary approach (e.g., two co-sponsors, one in a biotechnology company and the other in academia, for an early stage drug discovery and development project).
- Website
Contact
Tanya Stevenson, Myotonic Chief Executive Officer
[email protected]